Cryoport Systems - CYRX Net earnings per share for the last 12 months

This price chart illustrates the profit dynamics of Cryoport, Inc. (CYRX), which currently stands at 20.90. Business growth is fueled by demand for the transportation of fragile genetic preparations. Cryoport, Inc. (CYRX) generates revenue through the sale of cryogenic systems and the monitoring of biomaterial movement. Leadership in ultra-low temperatures and strict biocontrol create a high dependency of major pharmaceutical behemoths on this operator's technological capabilities.
CYRX (Cryoport Systems): analytical breakdowns and indicator data

Cryoport, Inc. (CYRX) benefits from the demand for cryogenic logistics and biomaterial monitoring for the pharmaceutical industry. The YoY EPS trend over the last 12 months reflects the annual growth rate of net income per share, smoothing out the volatility of one-time adjustments. Analyzing this trend allows for the separation of real operational growth from GAAP/Non-GAAP accounting manipulations. The steady movement of this indicator confirms the fundamental resilience of the business and minimizes the risk of a sudden collapse in share prices.